Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 355

• Price / Volume Information    Yesterday's Closing Price: $0.67 Daily Weekly Monthly 20 Day Moving Average: 540,000 shares Shares Outstanding: 44.58 (millions) Market Capitalization: $29.82 (millions) Beta: 1.52 52 Week High: $2.28 52 Week Low: $0.28 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.48% -7.33% 12 Week 51.35% 48.91% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 investors@harvardbioscience.com http://www.harvardbioscience.com

• General Corporate Information    Officers James Green - Chief Executive Officer and Director Jennifer Cote - Chief Financial Officer Katherine A. Eade - Director Alan Edrick - Director Thomas W. Loewald - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP.) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (PBSC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906105 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/11/26 Share - Related Items Shares Outstanding: 44.58 Most Recent Split Date: (:1) Beta: 1.52 Market Capitalization: $29.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/11/26

• Fundamental Ratios P/E Current FY Estimate: 6.08 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.12 Price/Cash Flow: 6.62 Price / Sales: 0.34 EPS Growth vs. Year Ago Period: 80.00% vs. Previous Quarter: 50.00% Sales Growth vs. Year Ago Period: -6.28% vs. Previous Quarter: 0.69% ROE 12/31/25 - - 09/30/25 - -2.29 06/30/25 - -5.64 ROA 12/31/25 - - 09/30/25 - -0.68 06/30/25 - -2.15 Current Ratio 12/31/25 - - 09/30/25 - 0.81 06/30/25 - 0.81 Quick Ratio 12/31/25 - - 09/30/25 - 0.41 06/30/25 - 0.41 Operating Margin 12/31/25 - - 09/30/25 - -0.71 06/30/25 - -2.53 Net Margin 12/31/25 - - 09/30/25 - -61.62 06/30/25 - -64.68 Pre-Tax Margin 12/31/25 - - 09/30/25 - -61.34 06/30/25 - -64.17 Book Value 12/31/25 - - 09/30/25 - 0.32 06/30/25 - 0.36 Inventory Turnover 12/31/25 - - 09/30/25 - 1.67 06/30/25 - 1.62 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©